Anuh Pharma Limited (ANUHPHR) — share transfer | 14 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Certificate received confirming no dematerialisation requests for Q1 FY2026
💡 Investor Takeaway
No share dematerialisation occurred in the latest quarter, indicating stable shareholding structure.

Anuh Pharma Limited received a SEBI Regulation 74(5) certificate from Bigshare Services confirming no dematerialisation requests for its equity shares during Q1 FY2026 (April-June 2026). The filing requests BSE and NSE to take the certificate on record.

📄 View Original Announcement (PDF)

About Anuh Pharma Limited (ANUHPHR)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹896.2 Cr P/E: 20.3 ROE: 12.5% ROCE: 17.2% Div Yield: 1.68%

View full ANUHPHR stock details →

📡 Get AI alerts when ANUHPHR files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ANUHPHR — Free

📊 More ANUHPHR filings

See all ANUHPHR filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ANUHPHR files new disclosures

Track ANUHPHR filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ANUHPHR — Free

Free account · 2 AI queries/day